Synergistic Effects of Curcumin and Piperine as Potent Acetylcholine and Amyloidogenic Inhibitors With Significant Neuroprotective Activity in SH-SY5Y Cells via Computational Molecular Modeling and in vitro Assay
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Hallmarks of Alzheimer’s disease (AD) pathology include acetylcholine deficiency and plaque deposition. Emerging studies suggest that acetylcholinesterase (AChE) may interact with amyloid beta (Aβ) to promote aggregation of insoluble amyloid beta plaques in brains of patients. Current therapeutic options available for AD patients, such as AChE inhibitors, provide only symptomatic relief. In this study, we screened four natural compounds believed to harbour cognitive benefits- curcumin, piperine, bacoside A and chebulinic acid. In the first section, preliminary screening through computational molecular docking simulations gauged the suitability of the compounds as novel AChE inhibitors. From here, only compounds that met the in silico selection criteria were selected for the second section through in vitro investigations, including AChE enzyme inhibition assay, MTT assay, ThT assay and biochemical analysis via a neuronal cell line model. Of the four compounds screened, only curcumin (-9.6kcal/mol) and piperine (-10.5kcal/mol) showed favorable binding affinities and interactions towards AChE and were hence selected. In vitro AChE inhibition demonstrated that combination of curcumin and piperine showed greater AChE inhibition with an IC50 of 62.81 ± 0.01μg/mL as compared to individual compounds, i.e., IC50 of curcumin at 134.5 ± 0.06µg/mL and IC50 of piperine at 76.6 ± 0.08µg/mL. In SH-SY5Y cell model, this combination preserved cell viability up to 85%, indicating that the compounds protect against Aβ-induced neuronal damage (p<0.01). Interestingly, our results also showed that curcumin and piperine achieved a synergistic effect at 35µM with SQ value of 1.824. Synergistic behavior indicates that combination of these two compounds at lower concentrations may provide a better outcome than individually for Aβ proteins. Combined curcumin and piperine managed to inhibit aggregation (reduced ThT intensity at 0.432a.u) (p<0.01) as well as disaggregation (reduced ThT intensity at 0.532a.u) (p<0.01) of fibrillar Aβ42. Furthermore, combined curcumin and piperine reversed the Aβ-induced up-regulation of neuronal oxidative stress (p<0.01). In conclusion, curcumin and piperine demonstrated promising neuroprotective effects whereas bacoside A and chebulinic acid may not be suitable lead compounds. These results are hoped to advance the field of natural products research as potential therapeutic and curative AD agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trott, O., & Olson, A. J. (2010) · Journal of Computational Chemistry · doi:10.1002/jcc.21334 · Cited by 38,412 · cited 1×
“The resulting AutoDock Vina output files in pdbqt format recorded the poses generated while the text data listed binding energies for the corresponding poses (Trott and Olson, 2010).”
BackgroundYang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336 · cited 1×
“Findings from an in vivo study revealed that curcumin inhibits Aβ aggregation as well as disaggregates to form fibrillar Aβ40 (Yang et al., 2005).”
BackgroundOxidative stress and the amyloid beta peptide in Alzheimer’s disease
Cheignon, C., Tomas, M., Bonnefont-Rousselot, D., Faller, P., Hureau, C., & Collin, F. (2018) · Redox Biology · doi:10.1016/j.redox.2017.10.014 · Cited by 2,185 · cited 2×
“In addition to plaque deposition, Aβ fibrils or soluble Aβ oligomers are intrinsically toxic to the cells by triggering the formation of reactive oxygen species (ROS), consequently attacking lipid membranes, which further facilitates lipid peroxidation while lowering the levels of first-line defense enzymes such as ca…”
BackgroundCarocho, M., & Ferreira, I. C. F. R. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.09.021 · Cited by 1,661
Synergy research: approaching a new generation of phytopharmaceuticals.
Wagner, H., & Ulrich-Merzenich, G. (2009) · Phytomedicine · doi:10.1016/j.phymed.2008.12.018 · Cited by 1,296
Ahmed, T., & Gilani, A.-H. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.09.010 · Cited by 301
Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors
Castro, A., & Martinez, A. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206778792985 · Cited by 207 · cited 1×
“A previous study has shown that AChE has secondary non-cholinergic functions including the processing and deposition of Aβ (Castro and Martinez, 2006).”
BackgroundOld and new acetylcholinesterase inhibitors for Alzheimer’s disease
Galimberti, D., & Scarpini, E. (2016) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2016.1216972 · Cited by 117
Gluthatione level is altered in lymphoblasts from patients with familial Alzheimer’s disease
Cecchi, C., Latorraca, S., Sorbi, S., Iantomasi, T., Favilli, F., Vincenzini, M. T., & Liguri, G. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00751-x · Cited by 101
Cited by
Afzal, S., Abdul Manap, A. S., Attiq, A., Albokhadaim, I., Kandeel, M., & Alhojaily, S. M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1269581 · Cited by 416
Self-citationZeng, L., Yu, G., Hao, W., Yang, K., & Chen, H. (2021) · Bioscience Reports · doi:10.1042/bsr20210817 · Cited by 120
Gao, L., Wang, J., & Bi, Y. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s549893 · Cited by 52
Curcumin and hesperetin attenuate D-galactose-induced brain senescence in vitro and in vivo
Lee, J., Kim, Y. S., Kim, E., Kim, Y., & Kim, Y. (2020) · Nutrition Research and Practice · doi:10.4162/nrp.2020.14.5.438 · Cited by 41
“Thus, it has been proposed that encapsulation or a combination administration can improve absorption [23-25].”
Background
Metadata
- Authors
- Abdul Manap, A. S., Wei Tan, A. C., Leong, W. H., Yin Chia, A. Y., Vijayabalan, S., Arya, A., Wong, E. H., Rizwan, F., Bindal, U., Koshy, S., & Madhavan, P.
- Venue
- Frontiers in Aging Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2019-08-27
- Volume
- 11
- Pages
- 206-206
- ISSN
- 1663-4365 (ISSN-L)
- OpenAlex
- W2964000120
- Cited by
- 110
- References
- 9
- FWCI
- 6.40
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.